Medicines, Poisons and Therapeutic Goods Regulation 2026
© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
Medicines, Poisons and Therapeutic Goods Regulation 2026
Start here
Turn the raw legal text into a practical explanation grounded in Medicines, Poisons and Therapeutic Goods Regulation 2026.
6 Existing authorities under former Act, section 29
(1) A medical practitioner or nurse practitioner who, immediately before the commencement date, held an authority issued under the former Act, section 29 (an existing authority) to supply or issue a prescription for a Schedule 8 substance, other than to a drug-dependent person as part of the Opioid Treatment Program, is taken, on the commencement date, to hold an approval under the new Act to supply, administer or issue a prescription for the same Schedule 8 substance to a patient.
(2) The approval is subject to the same conditions, if any, of the existing authority.
(3) The approval remains in force until the earlier of the following—
(a) the end of the period specified in the existing authority, if any,
(b) the surrender of the approval by the holder,
(c) the revocation of the approval by the Health Secretary under the new Act.